Haleon Invests in India to Deliver Better Everyday Health to Rural Communities

Article content

Article content

Article content

Article content

Article content

LONDON — Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million² in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia.

Article content

Article content

Article content

Building capacity to meet rising demand

Article content

The new site, which is well-positioned in the middle of the country and close to some of India’s most renowned technical colleges, marks an important step in the delivery of Haleon’s Win as One strategy. Win as One focuses on unlocking growth, driving productivity and transforming the company’s culture. Strengthening its in-house supply chain capabilities will enable Haleon to be more resilient and able to adapt faster to consumer needs.

Article content

Haleon’s investment in India reflects the clear, structural shift towards prevention and daily self-care, with the country’s consumer health market expected to reach over £23 billion by 2030. India is already one of Haleon’s largest oral health markets and this latest investment will accelerate access to its portfolio of trusted, science-backed brands including Sensodyne and parodontax across rural communities, with ambitions to reach more than three million outlets by 2030.

Article content

The investment is in line with Haleon’s capital allocation priorities as outlined at the company’s Capital Markets Day in 2025.

Article content

Reaching underserved communities at scale

Article content

Rural India is home to around 65% of the country’s population³, spread across more than 650,000 villages⁴, where unmet oral health needs remain significant. Access to dental care remains highly limited in rural India, where a single dentist may serve around 250,000 people⁵. With as few as 1 in 7 people in rural communities⁶ visiting a dentist each year, many live with untreated conditions like tooth decay or sensitivity for years. With many not currently using specialist toothpaste such as Sensodyne, recommended by healthcare professionals, there is a significant opportunity to address unmet consumer needs.

Article content

With many households reliant on daily wages and increasingly value conscious, Haleon will also be rolling out access to high-quality, science based oral health products made with trusted ingredients through lower-cost, small-format toothpaste packs – including its 20-rupee Sensodyne pack – across significantly more towns and villages.

Article content

Article content

With sales and distribution teams now working directly into Haleon’s leadership, there is significant opportunity to transform how products reach consumers in new and innovative ways – supported by the recruitment of more than 500 people to its sales teams over the last 12 months.

Article content

‘Last-mile’ investment to build awareness and access

Article content

Haleon is also investing in ‘last-mile’ capabilities, doubling frontline teams on motorbikes who are equipped with testing kits, samples and diagnostic tools and deployed to rural areas, which are often beyond the reach of traditional retail and pharmacies. Simple diagnostic tools, such as ‘chill tests’ – where consumers assess sensitivity by drinking cold water – help consumers recognise symptoms they may have had for years and connect them with science-backed treatment, often for the first time.

Article content

The company is also improving access by engaging rural communities directly through education, with its network of mobile oral health literacy vans. These Sensodyne-branded vans are designed to turn local squares and marketplaces into community hubs for oral health awareness, sensitivity and gum health checks, and immediate access to products.

Article content

Brian McNamara, CEO, Haleon, said:

Article content

“India is a key strategic market for Haleon and an important driver of our long-term growth. This investment strengthens our local manufacturing footprint and expands our reach in one of the world’s fastest-growing consumer health markets. By increasing access to our trusted brands and building our capabilities on the ground, we are well positioned to capture the significant opportunities ahead.

Article content

“We aim to expand access to better everyday health for more than 300 million additional consumers in India. This will be key to achieving our broader ambition to reach one billion more consumers globally by 2030.”

Article content

The new manufacturing facility was marked by a groundbreaking ceremony and a meeting between Haleon management and the Chief Minister of Madhya Pradesh this week. It will create up to 500 jobs, strengthen local capabilities and support long-term economic development, reinforcing Haleon’s ambition to be an employer of choice in the country. It is expected to open in early 2028 with supply commencing the following year.

Article content

Notes to editors Q&A

Article content

Why is Haleon investing in India?

Article content

India is one of Haleon’s fastest growing markets and key to achieving its ambition to reach one billion more consumers by 2030. The country’s consumer health market is forecast to reach over £23 billion by 2030, driven by rising awareness and adoption of self-care. Significant unmet health needs in rural areas, where access to care remains limited and many consumers do not yet use specialist products, create substantial headroom for growth and an opportunity to expand access to everyday health.